Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05188404 · ClinicalTrials.gov registry record
Aging and Marijuana: Benefits, Effects, and Risks
A clinical trial, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- 326
- Enrollment target
NCT05188404: Completed study, sponsored by University of Colorado, Boulder.
NCT05188404 is a clinical trial that has completed, run by University of Colorado, Boulder. The registered enrollment target is 326 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05188404 has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- 326 participants
- Enrollment target
Study Summary
Investigators will gather data on both the beneficial and harmful effects of edible cannabis of varying composition (THC-only vs. CBD-only vs. THC+CBD), and will examine the process by which older adult cannabis users decide what type of cannabis product is preferred.
Primary Outcome
Self report of whether symptoms have improved, gotten worse, or stayed the same
Interventions
- BEHAVIORAL Choice of cannabis product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 326 participants |
| Start Date | 2021-09-20 |
| Est. Completion | 2025-05-25 |
What the finished NCT05188404 record still lists
NCT05188404 is an observational study that tracks outcomes without assigning an intervention. The registered 326 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Choice of cannabis product is the first listed.
NCT05188404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05188404 about?
NCT05188404 is a clinical study titled "Aging and Marijuana: Benefits, Effects, and Risks". Investigators will gather data on both the beneficial and harmful effects of edible cannabis of varying composition (THC-only vs. CBD-only vs. THC+CBD), and will examine the process by which older adult cannabis users decide what type of cannabis product is preferred.
What is the current status of trial NCT05188404?
This trial is currently completed. The enrollment target is 326 participants. The study started on 2021-09-20. Estimated completion is 2025-05-25.
What interventions are being tested in trial NCT05188404?
The interventions under investigation include: Choice of cannabis product (BEHAVIORAL).
Who is sponsoring clinical trial NCT05188404?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06410144 · 326 participants · NA
Chronic Kidney Disease-Education (CKD-EDU)
- NCT06586619 · 326 participants · NA
A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
- NCT07040566 · 326 participants · Phase 2
A Trial of Varenicline for E-cigarette Cessation
- NCT07165860 · 326 participants · NA
Clinical Trial to Reduce Perinatal Intimate Partner Violence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI